640 related articles for article (PubMed ID: 17934392)
1. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
2. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
3. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
4. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
5. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
Després JP
J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
7. Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice.
Hecker PA; O'Shea KM; Galvao TF; Brown BH; Stanley WC
Horm Metab Res; 2011 Feb; 43(2):100-5. PubMed ID: 21165812
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome.
Otani H
Antioxid Redox Signal; 2011 Oct; 15(7):1911-26. PubMed ID: 21126197
[TBL] [Abstract][Full Text] [Related]
9. New insights into understanding cardiometabolic risk. Introduction.
Fonarow GC; Watson KE
Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
[No Abstract] [Full Text] [Related]
10. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
Barnett AH
Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806
[TBL] [Abstract][Full Text] [Related]
11. Adipokines at the crossroad between obesity and cardiovascular disease.
Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome: is it a syndrome? Does it matter?
Kahn R
Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
[No Abstract] [Full Text] [Related]
13. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
Bays H; Blonde L; Rosenson R
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):871-95. PubMed ID: 17173503
[TBL] [Abstract][Full Text] [Related]
14. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
Després JP
Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
[No Abstract] [Full Text] [Related]
15. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome and its cardiovascular manifestations.
Sánchez-Torres RJ; Delgado-Osorio H
Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
[TBL] [Abstract][Full Text] [Related]
18. The obesity epidemic and its cardiovascular consequences.
Behn A; Ur E
Curr Opin Cardiol; 2006 Jul; 21(4):353-60. PubMed ID: 16755205
[TBL] [Abstract][Full Text] [Related]
19. Obesity and metabolic syndrome as related to cardiovascular disease.
Nikolopoulou A; Kadoglou NP
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
[TBL] [Abstract][Full Text] [Related]
20. Identification of appropriate patients for cardiometabolic risk management.
Peters AL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]